Clinical Trials
(TRA016)
The Immunological Mechanism of Plasma EBV DNA Clearance during Radiotherapy in Patients with Nasopharyngeal Carcinoma-a pilot study
Chair:
Prof. Brigette Ma
Eligibility:
Adult patients with histologically confirmed non-keratinizing nasopharyngeal carcinoma previously untreated and are planned for curative treatment.Objectives:
To investigate changes in T-cell mediated immune response in patients undergoingRT alone or concurrent chemoradiotherapy (CRT) for nasopharyngeal carcinoma(NPC).
(TRA025)
Impact of Radiotherapy on the Dynamic Changes of Circulating Cell-free DNA in Patients with Hepatocellular Carcinoma
Chair:
Dr. Landon Chan